Skip to content

Comparative Study to Compare Safety and Efficacy of an Unani Toothpaste with Herbo-mineral Toothpaste in Patients with AmrÄ?d Al-AsnÄ?n-o-Litha (Periodontal Diseases)

A Single-Blind, Randomized, Parallel-Group Study to Compare Safety and Efficacy of an Unani Toothpaste with Herbo-mineral Toothpaste in Patients with AmrÄ?d Al-AsnÄ?n-o-Litha (Periodontal Diseases) - UTP

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050532
Enrollment
60
Registered
2023-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Herbal Tooth Paste: Natural remedies such as neem twigs, charcoal powder, and others have been an integral part of routine oral hygiene practice in rural areas of South Asian countries

Sponsors

Central Council for Research in Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Healthy male and non-pregnant female 2.Aged between 18 and 65 years. 3.Willing to give signed written informed consent 4.Subjects having AmrÄ?d al-AsnÄ?n (disease of the teeth) with or without any of the following symptoms: a.Bakhr al-Fam (halitosis) b.Quruh al-Litha (gingival ulcer) c.Taharruk al-Asnan (odontoseisis) d.Waram al-Lissa (gingival swelling) e.Humra al-Lissa (gingival erythema) f.Nazf al-Lisa (gingival bleeding) g.Dhahab Maâ?? al-Asnan (sensitive teeth) h.Wajaâ?? al-AsnÄ?n (toothache)

Exclusion criteria

Exclusion criteria: Requirement for prophylactic antibiotic medication, 1.Unable to comply with a study schedule, 2.Untreated caries 3.Periodontitis requiring prompt treatment or 4.Emergency dental treatment, 5.Wearing any kind of oral appliance, 6.History of known allergies 7.Known case of Hemophilia, Low platelet count (thrombocytopenia) and von Willebrand disease (VWD), etc. 8.Known cases of any other acute illness. 9.Known cases of systemic disorders requiring prolonged treatment. 10.Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Safety of the patientsTimepoint: 14th day, 28th day

Secondary

MeasureTime frame
Efficacy of the toothpaste, VAS scoreTimepoint: 14th day, 28th day

Countries

India

Contacts

Public ContactDr Ahmed Minhajuddin

NRIUMSD

aarzu763@gmail.com09032519286

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026